Zachary Brennan is senior editor for Endpoints, covering the US regulatory agency and others around the globe. He previously wrote about the FDA, Covid-19, and the biopharma industry for POLITICO, and was managing editor for the Regulatory Affairs Professionals Society's news publication. A DC-area native, he majored in English at Northwestern University.
Sign up for free to read a limited number of articles each month.About You
Pick what newsletters get delivered to your inbox each week.
Want unlimited access? Sign up for a premium subscription plan.
Join over 187,100 biopharma colleagues who rely on Endpoints News every business day for the latest developments in drug discovery, development, and commercialization.